Stay updated with breaking news from Michaelf Brigham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22.02.2022 - Annual Product Sales for 2021 Increased 25% over 2020PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) - ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets ...
the First Quarter Ended March 31, 2021 For Immediate Release PORTLAND, Maine - May 6, 2021 - ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2021 after the market closes on Thursday, May 13, 2021. The Company has scheduled a conference call the next morning, Friday, May 14, 202...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImmuCell Closes $4,250,000 Equity Financing ImmuCell CorporationApril 14, 2021 GMT PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that it has closed an equity investment. On April 14, 2021, the Company issued the aggregate...
By Staff ImmuCell Corp. (Nasdaq: ICCC), a Portland biotech company that makes preventive health products for beef and dairy cattle, on Monday reported that sales revenue increased 12% in 2020, and has completed application for regulatory approval of a new product. Total sales grew by $1.6 million over the 2019 level to $15.3 million last year, the company said in a news release. Sales during the fourth quarter of 2020 were $3.7 million, up by $111,000, or 3%, from the same period in 2019. ImmuCell reported a net loss of $1 million, or 14 cents per share, for 2020, compared to n...
ImmuCell reports 2020 sales boost, new product update The Portland-based animal health company reported a 12% increase in sales and progress on its efforts to earn regulatory approval for a new product called Re-Tain. By STAFF REPORT Share ImmuCell Corp. reported a double-digit sales increase in 2020 and says it has made its last major submission to the U.S. Food and Drug Administration for a new product under development. The Portland-based animal health products maker, which produces immunity-boosting treatments for dairy and beef cattle, reported 2020 sales of $15.3 million on Monday, up...